The PU.1 and NF-EM5 binding motifs in the Igkappa 3' enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic Vkappa gene - PubMed (original) (raw)
The PU.1 and NF-EM5 binding motifs in the Igkappa 3' enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic Vkappa gene
M Kodama et al. Int Immunol. 2001 Nov.
Abstract
Somatic hypermutation is a key mechanism in generating Ig with higher affinities to antigen, a process known as affinity maturation. Using Igkappa transgenes, the 3' enhancer (kappaE3') has been shown to play an important role in introducing hypermutations. In order to identify the cis-acting elements that regulate hypermutagenesis, we have generated transgenic substrates containing mutations/deletions in the kappaE3' region. Here, we report that base substitutions in the kappaE3', either in the PU.1 or in the NF-EM5 binding motif, not only reduce the mutation rate but also disrupt the directed mutagenesis in the intrinsic hotspots of the Igkappa transgene.
Similar articles
- A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S, Park K, Farrar MA, Atchison ML. Hodawadekar S, et al. J Immunol. 2012 Mar 1;188(5):2276-84. doi: 10.4049/jimmunol.1102239. Epub 2012 Jan 25. J Immunol. 2012. PMID: 22279106 Free PMC article. - E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
Lazorchak AS, Schlissel MS, Zhuang Y. Lazorchak AS, et al. Mol Cell Biol. 2006 Feb;26(3):810-21. doi: 10.1128/MCB.26.3.810-821.2006. Mol Cell Biol. 2006. PMID: 16428437 Free PMC article. - The PU.1 binding site is a cis-element that regulates pro-B/pre-B specificity of Vkappa-Jkappa joining.
Hayashi R, Takemori T, Kodama M, Suzuki M, Tsuboi A, Nagawa F, Sakano H. Hayashi R, et al. J Immunol. 1997 Nov 1;159(9):4145-9. J Immunol. 1997. PMID: 9379006 - Monitoring and interpreting the intrinsic features of somatic hypermutation.
Neuberger MS, Ehrenstein MR, Klix N, Jolly CJ, Yélamos J, Rada C, Milstein C. Neuberger MS, et al. Immunol Rev. 1998 Apr;162:107-16. doi: 10.1111/j.1600-065x.1998.tb01434.x. Immunol Rev. 1998. PMID: 9602357 Review.
Cited by
- Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
Buerstedde JM, Alinikula J, Arakawa H, McDonald JJ, Schatz DG. Buerstedde JM, et al. PLoS Biol. 2014 Apr 1;12(4):e1001831. doi: 10.1371/journal.pbio.1001831. eCollection 2014 Apr. PLoS Biol. 2014. PMID: 24691034 Free PMC article. - Attracting AID to targets of somatic hypermutation.
Tanaka A, Shen HM, Ratnam S, Kodgire P, Storb U. Tanaka A, et al. J Exp Med. 2010 Feb 15;207(2):405-15. doi: 10.1084/jem.20090821. Epub 2010 Jan 25. J Exp Med. 2010. PMID: 20100870 Free PMC article. - Antibody diversification: mutational mechanisms and oncogenesis.
Frieder D, Larijani M, Tang E, Parsa JY, Basit W, Martin A. Frieder D, et al. Immunol Res. 2006;35(1-2):75-88. doi: 10.1385/IR:35:1:75. Immunol Res. 2006. PMID: 17003511 Review. - Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A, Xu Z, Wu X, Zan H, Casali P. Komori A, et al. Mol Immunol. 2006 Apr;43(11):1817-26. doi: 10.1016/j.molimm.2005.10.018. Epub 2006 Jan 10. Mol Immunol. 2006. PMID: 16412510 Free PMC article. - Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D, Iglesias-Ussel MD, Fan M, Shulman MJ, Scharff MD. Ronai D, et al. Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11829-34. doi: 10.1073/pnas.0505449102. Epub 2005 Aug 8. Proc Natl Acad Sci U S A. 2005. PMID: 16087866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources